Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials.
The Journal of dermatological treatment
View this publicationThe Journal of dermatological treatment
View this publicationPublication categories: Top publication
Nature communications
View this publicationPsychopharmacology
View this publicationJournal of immunology (Baltimore, Md. : 1950)
View this publicationCell death discovery
View this publicationThe Journal of dermatological treatment
View this publicationHematology (Amsterdam, Netherlands)
View this publicationInfection
View this publicationJournal of immunology (Baltimore, Md. : 1950)
View this publicationbioRxiv : the preprint server for biology
View this publication